Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Peter Ziniel"'
Autor:
David L. Williams, Peter Ziniel, Christina A. Bulman, Alexandre Taravaud, Fidelis Cho-Ngwa, Liwen Feng, Chelsea Fischer, Sébastien Pomel, Perle Latré de Laté, Philippe M. Loiseau, Louis Maes, Judy A. Sakanari, Elisabeth Davioud-Charvet
Publikováno v:
Molecules, Vol 25, Iss 5075, p 5075 (2020)
Molecules
Molecules, MDPI, 2020, 25 (21), pp.5075. ⟨10.3390/molecules25215075⟩
Molecules: a journal of synthetic chemistry and natural product chemistry
Volume 25
Issue 21
Molecules
Molecules, MDPI, 2020, 25 (21), pp.5075. ⟨10.3390/molecules25215075⟩
Molecules: a journal of synthetic chemistry and natural product chemistry
Volume 25
Issue 21
Neglected parasitic diseases remain a major public health issue worldwide, especially in tropical and subtropical areas. Human parasite diversity is very large, ranging from protozoa to worms. In most cases, more effective and new drugs are urgently
Autor:
Karthik, Krishnan, Peter, Ziniel, Hao, Li, Xiuli, Huang, Daniel, Hupalo, Nita, Gombakomba, Sandra Mendoza, Guerrero, Thoai, Dotrang, Xiao, Lu, Diana, Caridha, Anna R, Sternberg, Emma, Hughes, Wei, Sun, Daniel Y, Bargieri, Paul D, Roepe, Richard J, Sciotti, Matthew D, Wilkerson, Clifton L, Dalgard, Gregory J, Tawa, Amy Q, Wang, Xin, Xu, Wei, Zheng, Philip E, Sanderson, Wenwei, Huang, Kim C, Williamson
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Drug resistance is a constant threat to malaria control efforts making it important to maintain a good pipeline of new drug candidates. Of particular need are compounds that also block transmission by targeting sexual stage parasite
Publikováno v:
Antimicrobial Agents and Chemotherapy. 57:5969-5976
Schistosomiasis affects over 200 million people worldwide, with over 200,000 deaths annually. Currently, praziquantel is the only drug available against schistosomiasis. We report here that Schistosoma mansoni farnesyl diphosphate synthase ( Sm FPPS)
Autor:
Peter Ziniel, Larissa M. Podust, Andrew H. Barnard, Gregory R. J. Thatcher, David L. Williams, Bhargava Karumudi, Ethan M. S. Fisher
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 12, p e0004279 (2015)
PLoS neglected tropical diseases, vol 9, iss 12
PLoS Neglected Tropical Diseases
PLoS neglected tropical diseases, vol 9, iss 12
PLoS Neglected Tropical Diseases
Schistosomiasis affects millions of people in developing countries and is responsible for more than 200,000 deaths annually. Because of toxicity and limited spectrum of activity of alternatives, there is effectively only one drug, praziquantel, avail
Autor:
Jutta Wagner, Ralf Ignatius, Peter Ziniel, Frank P. Mockenhaupt, Ulrich Bienzle, Klaus Stark, Francis Danikuu, Thomas Weitzel, Stephen Danour, Andrew Seidu-Korkor, Louis Anyidoho, Eiman Saad, Klaus Reither, Andrea Djie-Maletz
Publikováno v:
Journal of Antimicrobial Chemotherapy. 61:1315-1318
Objectives: Information on antimicrobial susceptibility of bacterial pathogens is scarce in resourcepoor settings. We determined the susceptibility of bacterial enteric pathogens and faecal Escherichia coli isolates obtained from children in urban Ta
Autor:
Min He, Ting Li, Peter Ziniel, Valerie P. Kommer, David L. Williams, Wesley C. Van Voorhis, Gregory J. Crowther, Panqing He, Ming-Wei Wang, Qing Liu
Publikováno v:
Infectious Diseases of Poverty
Background Schistosomiasis, a parasitic disease also known as bilharzia and snail fever, is caused by different species of flatworms, such as Schistosoma mansoni (S. mansoni). Thioredoxin glutathione reductase (TGR) from S. mansoni (SmTGR) is a well-
Autor:
Klaus Reither, Peter Ziniel, Martin P. Grobusch, Robin Kobbe, Jürgen May, Ina Danquah, Ulrike Buchholz, Philipp Zanger, Harry Hoffman Abruquah, Frank P. Mockenhaupt
Publikováno v:
Malaria Journal, 9. BioMed Central
Malaria Journal
Malaria journal, 9. BioMed Central
Malaria Journal, Vol 9, Iss 1, p 244 (2010)
Malaria Journal
Malaria journal, 9. BioMed Central
Malaria Journal, Vol 9, Iss 1, p 244 (2010)
Background Intermittent preventive treatment in infants with sulphadoxine-pyrimethamine (IPTi-SP) reduces malaria morbidity by 20% to 33%. Potentially, however, this intervention may compromise the acquisition of immunity, including the tolerance tow
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene, 104(11), 713-719. Elsevier
The haemoglobin (Hb) variants HbS and HbC protect against severe malaria. Yet, the influence particularly of HbC on asymptomatic or mild Plasmodium infection is not well established. In a dry season cross-sectional survey among 2108 children aged 0.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f5f464cdb4e31a6e3760ee2a92776b
https://pure.amc.nl/en/publications/influence-of-haemoglobins-s-and-c-on-predominantly-asymptomatic-plasmodium-infections-in-northern-ghana(2bf9251e-4451-40b8-a29d-eb5d6bfe4b8e).html
https://pure.amc.nl/en/publications/influence-of-haemoglobins-s-and-c-on-predominantly-asymptomatic-plasmodium-infections-in-northern-ghana(2bf9251e-4451-40b8-a29d-eb5d6bfe4b8e).html
Autor:
Ulrich Bienzle, Klaus Reither, Ekkehart Dietz, Ina Danquah, Peter Ziniel, Frank P. Mockenhaupt, Philipp Zanger
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:601-601
Intermittent preventive treatment in infants with sulfadoxine-pyrimethamine (IPTi-SP) reduces malaria episodes by 20 to 59% across Africa. This protective efficacy, however, may be affected by the high frequency of malnutrition in African infants. We
Autor:
Ulrich Bienzle, Felix Roepcke, Ina Danquah, Marc Frempong, Rowland N. Otchwemah, Sylvester D. Anemana, Peter Ziniel, P. Agana-Nsiire, Felicia Amoo-Sakyi, Frank P. Mockenhaupt, Klaus Reither, Jakob P. Cramer, Ekkehart Dietz, Eiman Saad, Philipp Zanger, Stephen Y. Dzisi
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:600-600
Morbidity and mortality from malaria remain unacceptably high among young children in sub-Saharan Africa. Intermittent preventive treatment in infancy (IPTi) involves the administration of antimalarials alongside routine vaccinations and might be an